Clinical Trial Update: Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

This clinical trial update reports on a novel gamma-delta (γδ) T cell therapy being studied for newly diagnosed glioblastoma in adults; the Phase 1 trial is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• gamma-delta T cell therapy (gamma-delta T cells)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Brain Tumor Adult | Phase 1 | Status: ACTIVE_NOT_RECRUITING